HOME  | CONTACT  | PATIENT LOGIN  | CLINIC LOGIN  | FAQ
  • PATIENTS &
    HEALTHY VOLUNTEERS
  • INVESTIGATORS
  • CROS / SPONSORS
  • CAREERS
  • TRIAL ALERTS

TRIALS SEARCH
      
  • HEALTH NEWS

  • RSS FEEDS

  • ABOUT TRIALS

  • LINK TO US


View Clinical Trial (Medical Research Study)


Mindfulness Mediation Intervention in COPD

Signup
Browse Studies

City:   Ann Arbor
State:   Michigan
Zip Code:   48109
Conditions:   Chronic Obstructive Pulmonary Disease
Purpose:   The purpose of this study is to assess the feasibility and potential impact of an eight week program of meditation on expiratory time, anxiety and dyspnea in people with COPD.
Study Summary:   Chronic Obstructive Pulmonary Disease is a progressive multi-dimensional disease with a complex network of somatic and affective components. Anxiety is a common experience for persons with COPD both as a reaction to dyspnea (48) and as a separate co-morbid condition (10, 26). The presence of anxiety magnifies COPD symptoms and further impairs physical functioning (53). Both anxiety and COPD alter breathing patterns similarly causing irregular rapid shallow breathing at rest, which is inefficient and cannot adequately respond to increases in ventilatory demands from physical or emotional activity (121). Both COPD and anxiety are also associated with changes in neurological functioning. Whereas anxiety tends to be associated with increased amygdala activity (54), COPD is associated with a decrease in frontal cortex functioning (25, 28, 122). Persons with COPD who experience anxiety are less able to correctly process the level of physical and emotional demand for any given situation and their ability to meet that demand (46, 123). Pulmonary rehabilitation addresses both the physical and emotional symptoms of COPD, however gains in function are quickly lost over time (4). Evidence suggests that mindfulness based meditation can alter neural pathways to facilitate processing of emotions and increase quality of life for persons with COPD. The overall objective of this study is to assess the ability of persons with COPD to participate in a mindfulness meditation intervention and to examine the impact of mindfulness meditation on their anxiety levels and global sense of coherence. A modified version of Antonovsky's sense of coherence model will be used as the framework for this study. We will address the specific aims: 1) to determine the effects of mindfulness meditation on breathing patterns; 2) To determine the effects of mindfulness meditation on anxiety levels; 3) To determine self-reported adherence rates following an eight-week small group instructional course on mindfulness meditation, and 4) To determine the effects of mindfulness meditation on global sense of coherence levels in persons with COPD. The National Center for Complementary and Alternative Medicine identifies meditation as a form of CAM that focuses on the interaction among the brain, body, mind and behavior that is already practiced by 8% of persons who participate in CAM therapy. Meditation is rated a special priority research area by NCCAM.
Criteria:   Inclusion Criteria: - Any stage of Chronic Obstructive Pulmonary Disease - Able to read and write English Exclusion Criteria: - Severe mental disability - Inability to attend
NCT ID:   NCT01577329
Primary Contact:   Principal Investigator
Roxane R Chan, RN, PhD (c)
University of Michigan

Roxane R Chan, RN, PhD (c)
Phone: 734-478-0170
Email: rrchan@umich.edu
Backup Contact:   N/A
Location Contact:   Ann Arbor, Michigan 48109
United States

Roxane R Chan, RN, PhD (c)
Phone: 734-478-0170
Email: rrchan@umich.edu

Site Status: Recruiting

Click here to see:
  • Clinical trials for Chronic Obstructive Pulmonary Disease in Ann Arbor, Michigan

Data Source:   ClinicalTrials.gov
Date Processed:   May 25, 2013
Modifications to this listing:   Only selected fields are shown, please use the link below to view all information about this clinical trial.
Click to view Full Listing


If you would like to be contacted by the clinical trial representative please enter your contact information, then click "I Am Interested In This Study"
First Name:  
Last Name:  
Email Address:  
Confirm Email:    
Daytime Phone (eg. 555-555-5555):  
City:  
State:
Zip Code:    
Best Time to Call:  
Questions/Comments:  
  • NEARBY STUDIES

Within 25 Miles

Crohn's Disease - Ypsilanti MI

Gout - Southfield MI

Postherpetic Neuralgia (Post-Shingles Pain) - Ann Arbor MI

Restless Legs Syndrome (RLS) - Farmington MI

Irritable Bowel Syndrome (with diarrhea) - Southfield MI

Postherpetic Neuralgia (Post-shingles pain) - Southfield MI

Within 50 Miles

Crohn's Disease - Troy MI

Crohn's Disease - Troy MI

Excessive Daytime Sleepiness with Narcolepsy - Toledo OH

Low Back Pain and Constipation - Rochester MI

Postherpetic Neuralgia (Post-shingles pain) - Brigham Farms MI

Within 100 Miles

Irritable Bowel Syndrome with Diarrhea (IBS-D) - New Baltimore MI

Gout - Perrysburg OH

Irritable Bowel Syndrome (with diarrhea) - Saginaw MI

Postherpetic Neuralgia (Post-shingles pain) - Bay City MI

Chronic Low Back Pain - Bay City MI

Low Back Pain and Constipation - Bay City MI

Postherpetic Neuralgia (Post-shingles pain) - Bay City MI

Diabetes (with Asthma, Emphysema or Chronic Bronchitis) - Flint MI

Uncontrolled Angina (Adult Stem Cell Research) - Saginaw MI

Arthritis - Tiffin OH

 
Clinical Connections Home | Investigators | CROs / Sponsors | Clinical Trials Notification | Search Clinical Trials | About Clinical Trials | Links | Terms And Conditions | Sitemap | Suggestions / Feedback
© 1998-2013 | All trademarks are property of their legal owners. | All Rights Reserved

ClinicalConnection.com is a resource that provides individuals with information regarding clinical trials that are being conducted worldwide.

ClinicalConnection.com does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating.